Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boudjelal

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Endocrinology (Baltimore, Md.)|October 12, 1999
1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skinX Y Li, M Boudjelal, J H Xiao, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 19, 2008
Sequencing and functional assessment of hPXR (NR1I2) variants in intrahepatic cholestasis of pregnancyB M Owen, S W C Van Mil, M Boudjelal, et al.
Journal of Infection and Public Health|November 27, 2022
The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)M Al Ghobain, F Rebh, A Saad, et al.
SAR and QSAR in Environmental Research|November 25, 2021
Discovery of Zafirlukast as a novel SARS-CoV-2 helicase inhibitor using in silico modelling and a FRET-based assayN Mehyar, A Mashhour, I Islam, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Endocrinology (Baltimore, Md.)|October 12, 1999
1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skinX Y Li, M Boudjelal, J H Xiao, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 19, 2008
Sequencing and functional assessment of hPXR (NR1I2) variants in intrahepatic cholestasis of pregnancyB M Owen, S W C Van Mil, M Boudjelal, et al.
Journal of Infection and Public Health|November 27, 2022
The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)M Al Ghobain, F Rebh, A Saad, et al.
SAR and QSAR in Environmental Research|November 25, 2021
Discovery of Zafirlukast as a novel SARS-CoV-2 helicase inhibitor using in silico modelling and a FRET-based assayN Mehyar, A Mashhour, I Islam, et al.
Pageof 2